Nkafu Bechem Ndemazie

Dr. Nkafu Bechem Ndemazie

Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CDChristian Akem Dimala
Christian Akem Dimala
BKBenjamin Momo Kadia
Benjamin Momo Kadia
MNMiriam Aiwokeh Mbong Nji
Miriam Aiwokeh Mbong Nji
Nkafu Bechem NdemazieNkafu Bechem Ndemazie
Nkafu Bechem Ndemazie
There have been growing concerns of a potential re-establishment of measles transmission in the United States (US) in the years to come. This study aims to explore potential factors underlying the resurgence of measles in the US by objectively assessing the associations between annual incidence rates (AIR), case importation, vaccination status and disease outbreaks. Data on measles transmission between January 1st, 2001 and December 31st, 2019 were obtained from the national centres for disease control and prevention (CDC) surveillance databases and other published reports. Changes in incidence rates over time were assessed by binomial regression models. Of the 3874 cases of measles in the US over the study period, 3506 (90.5%, 95% CI: 89.5–91.4) occurred in US residents. The AIR per million population in US residents over this period was 0.60 (95% CI: 0.59–0.61), with an overall significant increase over time (p = 0.011). The median percentage of imported and vaccinated cases were 36% [17.9–46.6] and 15% [12.1–23.2] respectively. There was a significant decrease in the percentage of imported cases (p < 0.001) but not of vaccinated cases (p = 0.159) over time. There was a moderate and weak negative correlation between the AIR and the percentage of imported and vaccinated cases respectively (r = –0.59 and r = –0.27 respectively). On multiple linear regression there was a significant linear association between the AIR and the number of outbreaks (p = 0.003) but not with the percentage of imported cases (p = 0.436) and vaccinated cases (p = 0.692), R2 = 0.73. Strong negative and positive correlations were seen between the number of outbreaks and the percentage of imported cases (r = –0.61) and the of number states affected (r = 0.88) respectively. Despite the overall reduction in the percentage of imported cases of measles over the past two decades, pockets of internal transmission of the disease following importation via increasing number of outbreaks in unvaccinated subpopulations, reinforced by vaccine hesitancy, account for the sustained increase in measles incidence rates in the US. Controlling indigenous transmission through efficient vaccination coverage in at-risk subpopulations and among international US travellers, improved disease surveillance and rapid outbreak containment are essential in curbing the measles resurgence.

3 December 2021 in AAPS PharmSciTech
Verified
Journal Article
Open access
PDF file
Nkafu Bechem NdemazieNkafu Bechem Ndemazie
Nkafu Bechem Ndemazie
AIAndriana Inkoom
Andriana Inkoom
EMEllis Fualefeh Morfaw
Ellis Fualefeh Morfaw
TSTaylor Smith
Taylor Smith
MAMonica Aghimien
Monica Aghimien
EAEdward Agyare
Edward Agyare
Drug delivery into the brain has for long been a huge challenge as the blood–brain barrier (BBB) offers great resistance to entry of foreign substances (with drugs inclusive) into the brain. This barrier in healthy individuals is protective to the brain, disallowing noxious substances present in the blood to get to the brain while allowing for the exchange of small molecules into the brain by diffusion. However, BBB is disrupted under certain disease conditions, such as cerebrovascular diseases including acute ischemic stroke and intracerebral hemorrhage, and neurodegenerative disorders including multiple sclerosis (MS), Alzheimer’s disease (AD), Parkinson’s disease (PD), and cancers. This review aims to provide a broad overview of present-day strategies for brain drug delivery, emphasizing novel delivery systems. Hopefully, this review would inspire scientists and researchers in the field of drug delivery across BBB to uncover new techniques and strategies to optimize drug delivery to the brain. Considering the anatomy, physiology, and pathophysiological functioning of the BBB in health and disease conditions, this review is focused on the controversies drawn from conclusions of recently published studies on issues such as the penetrability of nanoparticles into the brain, and whether active targeted drug delivery into the brain could be achieved with the use of nanoparticles. We also extended the review to cover novel non-nanoparticle strategies such as using viral and peptide vectors and other non-invasive techniques to enhance brain uptake of drugs. Graphical abstract

10 January 2016 in International Journal of TROPICAL DISEASE & Health
Verified
Journal Article
Open access
PDF file
GHGregory Edie Halle-Ekane
Gregory Edie Halle-Ekane
FEFrancine Ketchem Emade
Francine Ketchem Emade
Nkafu Bechem NdemazieNkafu Bechem Ndemazie
Nkafu Bechem Ndemazie
JPJohn N. Palle
John N. Palle
DFDuplex Fongaing
Duplex Fongaing
NFNelson Fomulu
Nelson Fomulu
Background: Approximately 800 women die from pregnancy-related conditions daily with 99% of these maternal deaths occurring in low resource countries. Primary postpartum haemorrhage accounts for 25.7% of maternal deaths in Africa. In Cameroon, primary postpartum hemorrhage remains the leading cause of maternal death. Objective: The aim of this study was to determine the prevalence, risk factors, and the maternal and fetal outcomes of primary postpartum hemorrhage in the Bonassama District Hospital, Douala, Cameroon. Methods: This study was a cross-sectional study. Of the 556 women interviewed regarding their willingness to participate in the study, 550 consented. Quantification of blood loss was done over the 24 hours using a 700cc measuring cylinder, an electronic weighing balance and the Pathfinder International wall chart for visual estimation of blood loss. The well-being of the neonates was evaluated by a pediatrician. Data was collected using a structured questionnaire and analyzed using EPI-INFOTM version 7.1.4.0. A P-value <0.05 used to determine association between variables was considered statistically significant. Results: The prevalence of primary postpartum hemorrhage was 23.6%. The risk factors of primary postpartum hemorrhage were: previous postpartum hemorrhage (aO.R=6.50; 95% C.I=4.60-9.20), multiparity (aO.R=7.02; 95% C.I=5.27-8.02), prolonged labor (aO.R= 1.1; 95% C.I=1.01-6.61) and macrosomia (aO.R=8.18; 95% C.I= 5.53-8.51). The main causes of PPH were uterine atony and obstetrical lacerations (P-value<0.01). Two (1.5%) maternal and 2 (0.4%) perinatal deaths were recorded. Conclusion: The prevalence of postpartum hemorrhage was high. The main cause of primary post-partum hemorrhage was uterine atony. Primary PPH was associated with uterine hypotonia, placenta retention and genital lacerations. The maternal and perinatal mortality were high. These findings highlight the pressing need for good quality emergency obstetric care and the availability of more accurate techniques of postpartum blood loss measurement. Secondly, hospitals need blood banks to manage patients with severe hemorrhage.

14 October 2015 in Women's Health - Open Journal
Verified
Journal Article
Open access
GHGregory E. Halle-Ekane
Gregory E. Halle-Ekane
CFCyril Mela Fotabong
Cyril Mela Fotabong
PNPhillip Nana Njotang
Phillip Nana Njotang
JAJulius Atashili
Julius Atashili
Nkafu Bechem NdemazieNkafu Bechem Ndemazie
Nkafu Bechem Ndemazie
TOThomas Egbe Obinchemti
Thomas Egbe Obinchemti
Introduction: The outcome of pregnancy depends, to a large extent, on the availability and effectiveness of antenatal care. Unskilled care before, during and after child birth, late start andinconsistent attendance of Antenatal care (ANC), and poor ANC package are seen frequently.However, the extent to which these practices affect pregnancy outcome are not known in FakoDivision, South West Region, Cameroon.Objective: The objective of this study was to determine the relationship between the outcomeof pregnancy and the quality of ANC in the aforementioned setting.Patients and Methods: This was a hospital based cross-sectional study that involved 300 immediate post-partum women in three hospitals in Fako Division, Cameroon. Data was collectedusing a structured questionnaire in a two-step manner; face-to-face interview, and from women’s case notes during ANC and their delivery records. Data was analyzed using Epi Info™version 7.1.4.0 (CDC, Atlanta, USA, 2015) statistical software.Results: Mean gestational age at start of ANC was 19.2 weeks (SD 4.2 years), 99% of participants attended at least one ANC consultation, 15.5% started ANC early; 58% attended ≥4ANC visits. Six-seven percent of them received adequate care. There was a strong negativecorrelation between gestational age at start of ANC and overall adequate care (p-value 0.001).Inadequate care, being a teenager, and single were associated with adverse pregnancy outcomes. Inadequate care was also associated with pre-term birth, post-term birth, labour induction, dystocia, labour augmentation, stillbirth, low APGAR score, and low birth weight. (Allp-values <0.05).Conclusion: Adverse pregnancy outcomes in this region were associated with poor qualityANC. Sensitization of women on the benefit of quality ANC, better health care services withwell-trained health care personnel, and research to find out a more precise diagnosis of causesof adverse foeto-maternal outcomes will lead to reduced fetal and maternal morbidity and mortality.

Verified
Journal Article
Open access
PDF file
Nkafu Bechem NdemazieNkafu Bechem Ndemazie
Nkafu Bechem Ndemazie
RBRaviteja Bulusu
Raviteja Bulusu
XZXue You Zhu
Xue You Zhu
EFEsther Kesewaah Frimpong
Esther Kesewaah Frimpong
AIAndriana Inkoom
Andriana Inkoom
EAEdward Agyare
Edward Agyare
Pancreatic cancer is projected to be the second leading cause of cancer-related death by 2030 in the US. The benefits of the most common systemic therapy for various pancreatic cancers have been masked by high drug toxicities, adverse reactions, and resistance. The use of nanocarriers such as liposomes to overcome these unwanted effects has become very popular. This study aims to formulate 1,3-bistertrahydrofuran-2yl-5FU (MFU)-loaded liposomal nanoparticles (Zhubech) and to evaluate itsstability, release kinetics, in vitro and in vivo anticancer activities, and biodistribution in different tissues. Particle size and zeta potential were determined using a particle size analyzer, while cellular uptake of rhodamine-entrapped liposomal nanoparticles (Rho-LnPs) was determined by confocal microscopy. Gadolinium hexanoate (Gd-Hex) was synthesized and entrapped into the liposomal nanoparticle (LnP) (Gd-Hex-LnP), as a model contrast agent, to evaluate gadolinium biodistribution and accumulation by LnPs in vivo using inductively coupled plasma mass spectrometry (ICP-MS). The mean hydrodynamic diameters of blank LnPs and Zhubech were 90.0 ± 0.65 nm and 124.9 ± 3.2 nm, respectively. The hydrodynamic diameter of Zhubech was found to be highly stable at 4 °C and 25 °C for 30 days in solution. In vitro drug release of MFU from Zhubech formulation exhibited the Higuchi model (R2 value = 0.95). Both Miapaca-2 and Panc-1 treated with Zhubech showed reduced viability, two- or four-fold lower than that of MFU-treated cells in 3D spheroid (IC50Zhubech = 3.4 ± 1.0 μM vs. IC50MFU = 6.8 ± 1.1 μM) and organoid (IC50Zhubech = 9.8 ± 1.4 μM vs. IC50MFU = 42.3 ± 1.0 μM) culture models. Confocal imaging confirmed a high uptake of rhodamine-entrapped LnP by Panc-1 cells in a time-dependent manner. Tumor-efficacy studies in a PDX bearing mouse model revealed a more than 9-fold decrease in mean tumor volumes in Zhubech-treated (108 ± 13.5 mm3) compared to 5-FU-treated (1107 ± 116.2 mm3) animals, respectively. This study demonstrates that Zhubech may be a potential candidate for delivering drugs for pancreatic cancer treatment.

5 January 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
BNBibiana Ateh Nzeangung
Bibiana Ateh Nzeangung
MBMartin Essomba Biwole
Martin Essomba Biwole
BKBenjamin Momo Kadia
Benjamin Momo Kadia
Nkafu Bechem NdemazieNkafu Bechem Ndemazie
Nkafu Bechem Ndemazie
CDChristian Akem Dimala
Christian Akem Dimala
ASAlbert Mouelle Sone
Albert Mouelle Sone
Breast cancer has a high case fatality rate in sub-Saharan Africa, and this is chiefly because of late detection and inadequate treatment resources. Progressive renovations in diagnostic and management modalities of non-metastatic breast cancer (NMBC) have been noted in the region but there is paucity of data describing the clinical progress of patients with NMBC. This study sought to determine the rates of local relapse, distant metastasis and sequelae and the time span from initial treatment to the occurrence of these adverse events among patients with NMBC. This was a retrospective review of medical records of patients with histologically confirmed NMBC at the department of radiation therapy and oncology of the Douala General Hospital in Cameroon from the January 1997 to December 2012 period. Clinicopathological and treatment characteristics as well as occurrences of adverse events were studied. A total of 260 cases were reviewed of which 224/260 (86.2%) had invasive ductal carcinoma. Surgery was performed on 258/260 cases (99.2%) with 187/258 (72.5%) being modified radical mastectomies. Various treatment combinations were used in up to 228/260 patients (87.5%) while surgery alone was the treatment in the remaining 32 cases (12.5%). Metastasis occurred in 142/260 cases (54.6%) of which 68/142 (26.2%) were local relapses and 74/142 (28.5%) were distant metastases. Among the cases of distant metastasis, 9.2% were bone, 8.5% lungs, 6.9% nodal, and 5.4% brain. Metastasis to multiple organs was noted in 4.7% of these cases. The median periods of occurrence of local relapse and distant metastases were 13 and 12 months respectively. Sequelae occurred in 26/260 cases (10%) and were noted after an average of 30 months. The main sequelae were lymphoedema (6.5%) and lung fibrosis (1.5%). At the end of the period under review, 118/260 patients (45.4%) were alive and disease-free with a median follow up time of 24 months. Adverse events were frequent among patients who received primary treatment for NMBC. Available cancer therapeutic modalities ought to be supplemented with efficient strategies of follow-up and monitoring so as to optimize the care provided to these patients and improve on their survival.